Regulation of RelA (p65) function by the large subunit of replication factor C

被引:22
|
作者
Anderson, LA [1 ]
Perkins, ND [1 ]
机构
[1] Univ Dundee, Sch Life Sci, Div Gene Express & Regulat, Dundee DD1 5EH, Scotland
关键词
D O I
10.1128/MCB.23.2.721-732.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RelA (p65) subunit of NF-kappaB is an important regulator of inflammation, proliferation, and apoptosis. We have discovered that the large subunit, p140, of replication factor C (RFC) can function as a regulator of RelA. RFC is a clamp loader, facilitating the addition and removal of proliferating-cell nuclear antigen from DNA during replication and repair but can also interact directly with the retinoblastoma tumor suppressor protein and the transcription factor C/EBPalpha. We find that RFC (p140) interacts with RelA both in vitro and in vivo and stimulates RelA transactivation. In contrast, coexpression of fragments of RFC (p140) that mediate the interaction with RelA results in transcriptional inhibition. The significance of this regulation was confirmed by using short interfering RNA otigonucleotides targeted to RFC (p140). Down regulation of endogenous RFC (p140) inhibits expression from a chromosomally integrated reporter plasmid induced by endogenous, TNF-alpha-activated NF-kappaB. Dominant negative fragments of RFC (p140) also cooperate with overexpressed RelA to induce cell death. Interestingly, RFC (p140) also interacts with the tumor suppressor p53. Taken together, these observations suggest that, in addition to its previously described function in DNA replication and repair, RFC (p140) has an important rote as a regulator of transcription and NF-kappaB activity.
引用
收藏
页码:721 / 732
页数:12
相关论文
共 50 条
  • [41] PIAS3 suppresses NF-κB-mediated transcription by interacting with the p65/RelA subunit
    Jang, HD
    Yoon, K
    Shin, YJ
    Kim, J
    Lee, SY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) : 24873 - 24880
  • [42] The nuclear factor κB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation
    Hanson, JL
    Hawke, NA
    Kashatus, D
    Baldwin, AS
    CANCER RESEARCH, 2004, 64 (20) : 7248 - 7255
  • [43] Regulation of the replication initiator protein p65(cdc18) by CDK phosphorylation
    Jallepalli, PV
    Brown, GW
    MuziFalconi, M
    Tien, D
    Kelly, TJ
    GENES & DEVELOPMENT, 1997, 11 (21) : 2767 - 2779
  • [44] Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor κB response
    Saccani, S
    Marazzi, I
    Beg, AA
    Natoli, G
    JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (01): : 107 - 113
  • [45] The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-κB
    C J Loveridge
    A D H MacDonald
    H C Thoms
    M G Dunlop
    L A Stark
    Oncogene, 2008, 27 : 2648 - 2655
  • [46] RELA/P65 IS A MOLECULAR TARGET FOR THE IMMUNOSUPPRESSIVE ACTION OF PROTEIN-KINASE-A
    NEUMANN, M
    GRIESHAMMER, T
    CHUVPILO, S
    KNEITZ, B
    LOHOFF, M
    SCHIMPL, A
    FRANZA, BR
    SERFLING, E
    EMBO JOURNAL, 1995, 14 (09): : 1991 - 2004
  • [47] Post-translational modification of RelA(p65) NF-κ B
    Campbell, KJ
    Perkins, ND
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 1087 - 1089
  • [48] Cyclophilin A (CypA) Interacts with NF-κB Subunit, p65/RelA, and Contributes to NF-κB Activation Signaling
    Sun, Shan
    Guo, Mian
    Zhang, James Beiji
    Ha, Albert
    Yokoyama, Kazunari K.
    Chiu, Robert H.
    PLOS ONE, 2014, 9 (08):
  • [49] The RelA(p65) subunit of NF-κB is essential for inhibiting double-stranded RNA-induced cytotoxicity
    Li, M
    Shillinglaw, W
    Henzel, WJ
    Beg, AA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) : 1185 - 1194
  • [50] The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-κB
    Loveridge, C. J.
    MacDonald, A. D. H.
    Thoms, H. C.
    Dunlop, M. G.
    Stark, L. A.
    ONCOGENE, 2008, 27 (18) : 2648 - 2655